CDKN2A and hepatocellular carcinoma: However, the mutations detected in CDKN2A (rs200429615 and rs1587332314) and ATM (rs79220522) were classified as deleterious, implying a detrimental effect on protein function and a potential role in HCC pathogenesis (Figure 3b).